Influx Healthtech IPO Oversubscribed On Day 3; GMP at Rs. 38 Hints at Nearly 40% Listing Premium on NSE SME

The Rs 55.63 crore Influx Healthtech IPO received an overwhelming response from investors, closing with a total subscription of 25.47 times on the second, and the subscription data for the final day of bidding is awaited. Backed by strong interest from retail and non-institutional investors, the SME IPO is currently on investors radar and is now being closely watched for its upcoming allotment and listing on the NSE SME platform, which is expected next week, June 25.

Influx Healthtech IPO: Subscription Breakdown

Influx Healthtech IPO is seeing strong investor participation across all categories, closing with an impressive 25.47 times overall subscription by the end of day 2.

Qualified Institutional Buyers (QIBs) showed moderate interest in the IPO, subscribing 1.69 times their allotted quota.

Non-Institutional Investors (NIIs), which include high-net-worth individuals and corporate investors, came with huge demand, placing bids 32.28 times the shares reserved for their category.

Retail Individual Investors (RIIs) emerged as the most active participants in the IPO, with a massive 36.13 times subscription.

IPO Details: Price Band, Lot Size, and Investment Requirements

The Influx Healthtech IPO, open from June 18 to June 20, comprises a fresh issue of Rs. 45.07 crore and an offer for sale (OFS) of Rs. 10.56 crore. The IPO price band was fixed between Rs. 91 and Rs. 96 per share, with a face value of Rs. 10. Influx Healthtech IPO raises Rs. 16.67 crore from anchor investors. Influx Healthtech IPO anchor bid date is June 17, 2025.

Grey Market Premium (GMP) and Listing Expectations

The latest GMP for Influx Healthtech IPO stands at Rs. 38 as of June 20, 2025, 8:30 AM, suggesting a potential listing price of Rs. 134 per share. This indicates a likely premium of 39.58% over the upper issue price of Rs. 96 as per data from the Investorgain website.

Allotment and Listing Dates

The IPO allotment date is expected to be Monday, June 23, 2025, and the tentative listing date on the NSE SME exchange is Wednesday, June 25, 2025.

About Influx Healthtech

Influx Healthtech, a leading player in the healthcare manufacturing sector, operates certified facilities with GMP, HACCP, ISO 22000, and Halal accreditations. Founded in September 2020, the company specialises in contract development and manufacturing (CDMO) services. The company offers end-to-end solutions across various industries, catering to both domestic and international clients. The company operates three fully equipped manufacturing facilities located in Thane, Maharashtra, spanning 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft., respectively. These facilities are designed to meet stringent industry standards, enabling the company to deliver high-quality and scalable production services across pharmaceuticals, nutraceuticals, and wellness products.